Status: Recruiting
Enzalutamide Implants (Enolen) in Patients With Prostate Cancer
The study is to assess whether the Enolen is safe and delivers anti-androgen medication locally in patients that are planning for radical prostatectomy.
Participants needed: 45
Trial details
Phase: Phase 1Age: 21+Biological sex: MaleType: InterventionalSponsor: Alessa Therapeutics Inc.Updated: Aug 11, 2026Locations: 10
Eligibility criteria
Age at least 21 years old [+9]
Prior radiotherapy or surgery for prostate cancer [+12]